Tilray Inc (TLRY)
$19.81
1.12 (5.35%)
TLRY Stock Quote Delayed 15 Minutes
Previous Close
$19.81
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.71M
Day's Range
19.50 - 20.84
52-Week Range
19.50 - 120.40
Dividend & Yield
N/A (N/A)
TLRY Stock Predictions, Articles, and Tilray Inc News
Stock Market Today: Cannabis Gets Crushed
Walmart and Cisco stock beat on earnings, but fell on Thursday. Here's what happened in the stock market today.
Tilray Stock Has Fallen and Can’t Get Up
Tilray stock, along with the rest of the marijuana sector, have fallen out of favor and won't get back up. They need consistent profit.
High Hopes: Tilray Stock Needs a Miracle to Finish 2019 Strong
Investors justifiably have low expectations for TLRY stock ahead of quarterly earnings. Here's the outlook for Tilray through the end of 2019.
The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.
Why the Slide of Tilray Stock May Continue
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.
Is Tilray Stock About to Stage a Comeback?
Throughout 2019, Tilray stock and its cannabis peers have hemorrhaged market value. But a development within the sphere of cancer research has brought legitimacy to both TLRY and the broader industry.
Tilray Stock Short Sellers Need to Be Careful
Tilray has been one of the most profitable cannabis stocks to short in the past year. However, shorting TLRY stock at this point is a dangerous play.
Don’t Expect Tilray Stock to Recover Anytime Soon
Tilray's cash burn and regulatory issues make Tilray stock unattractive. Investors shouldn't buy TLRY stock yet.
Shareholders Worry as Tilray Stock Approaches IPO Price
If Tilray stock breaks the $17 level, the IPO price will become a resistance level. Investors should also expect short selling there.
Investors Beware: Tilray Stock Might Not Be Done Dropping
Tilray stock probably has further to fall since TLRY must overcome further funding obstacles before it can become a profitable company.
With Profitability Nowhere in Sight, Tilray Stock Has Further to Fall
Tilray stock tumbles as investors demand profitability. Tilray, like other cannabis stocks, is stuck in a death spiral as long as the copmany can't produce profits.
Plunging Tilray Stock Shows Just How Much Sentiment Has Changed
Tilray stock keeps falling and now is nearing its IPO price. Trading in TLRY stock shows how much faith investors have lost in pot stocks.
Has Tilray Stock Finally Hit Rock-Bottom?
It’s been absolutely grueling for Tilray stock. It seems like nothing can help shares. But interestingly enough, this may be setting up a good entry point for TLRY.
Tilray Stock Hammered as Investors Turn on Cannabis Producers
Revised earnings guidance for Hexo spooked the market and hit cannabis stocks, with Tilray stock closing down 13.5% on Thursday.
These Troubles Won’t Last for Tilray Stock, but They’re Not Fading Fast
Tilray stock's 52-week high is just under $179. On Friday, Oct. 4, the shares barely closed above $24. The outlook for Tilray and some of its marijuana rivals will improve at some point. Knowing when that point will arrive, well, that's a different ballgame. Over the near-term, things are problematic for Tilray stock because losses are accelerating. Over the past month, the shares are lower by 25% and the loss of the past quarter is almost double that.
Should Investors Have More Patience with Tilray Stock?
Opportunities abound for Tilray stock but the cannabis infrastructure still needs to be built out, along with more favorable legalization momentum. For now, TLRY is interesting, but it will require patience from investors.
Pretty Much Any Pot Play Makes More Sense Than Buying Tilray Stock
The company has several catalysts in play, but nothing unique compared to what other cannabis companies are doing. I remain on the fence with pot stocks in general. But if I were entering a position today, I would choose something like Hexo or Aphria to place my bet on the legalized marijuana story. I suggest you do the same. Look elsewhere for a pot play, but steer clear of TLRY stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
F
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
